| Original language | English |
|---|---|
| Pages (from-to) | e119 |
| Number of pages | 1 |
| Journal | The Lancet Haematology |
| Volume | 6 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Mar 2019 |
Cite this
}
Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma : not yet the standard of care. / Casan, Joshua ML; Barraclough, Alison; Shortt, Jake; Hawkes, Eliza A.
In: The Lancet Haematology, Vol. 6, No. 3, 01.03.2019, p. e119.Research output: Contribution to journal › Letter › Other › peer-review
TY - JOUR
T1 - Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma
T2 - not yet the standard of care
AU - Casan, Joshua ML
AU - Barraclough, Alison
AU - Shortt, Jake
AU - Hawkes, Eliza A.
PY - 2019/3/1
Y1 - 2019/3/1
UR - http://www.scopus.com/inward/record.url?scp=85061927815&partnerID=8YFLogxK
U2 - 10.1016/S2352-3026(19)30013-4
DO - 10.1016/S2352-3026(19)30013-4
M3 - Letter
VL - 6
SP - e119
JO - The Lancet Haematology
JF - The Lancet Haematology
SN - 2352-3026
IS - 3
ER -